EUVIMEDEUVIMED entdecken
Crossref

Access to biologics and JAK inhibitors for the treatment of rheumatic diseases in the biosimilars era in Poland: nation-level study

Marcin Stajszczyk iD, Brygida Kwiatkowska iD, Zbigniew M Żuber iD, Bogdan Batko iD

Polish Archives of Internal Medicine · 2024

DOI: 10.20452/pamw.16655 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Polish Archives of Internal Medicine, 2024. Verfasst von Marcin Stajszczyk und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Autoimmune Diseases, Silesian Center for Rheumatology, Orthopedics and Rehabilitation, Ustroń, Poland. marcin.stajszcz…. Hauptthemen laut MEDLINE: Biosimilar Pharmaceuticals, Antirheumatic Agents, Janus Kinase Inhibitors, Rheumatic Diseases. Die Arbeit wurde bisher 7-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biosimilar PharmaceuticalsAntirheumatic AgentsJanus Kinase InhibitorsRheumatic DiseasesHumansPolandRetrospective StudiesMaleFemaleMiddle AgedBiological ProductsAdultArthritis, PsoriaticArthritis, RheumatoidEtanercept

Substanzen

Biosimilar PharmaceuticalsAntirheumatic AgentsJanus Kinase InhibitorsBiological ProductsEtanercept

Autor:innen und Institutionen

  • Department of Rheumatology and Autoimmune Diseases, Silesian Center for Rheumatology, Orthopedics and Rehabilitation, Ustroń, Poland. marcin.stajszczyk@mp.pl
  • Early Arthritis Clinic, National Institute of Geriatrics, Rheumatology and Rehabilitation, Warsaw, Poland
  • Department of Pediatrics, Faculty of Medicine and Health Sciences, Andrzej Frycz Modrzewski Krakow University, Kraków, Poland
  • Department of Rheumatology and Immunology, Faculty of Medicine and Health Sciences, Andrzej Frycz Modrzewski Krakow University, Kraków, Poland

ORCID-Profile: Marcin Stajszczyk, Brygida Kwiatkowska, Zbigniew M Żuber, Bogdan Batko

Zitieren

APA

Stajszczyk, M., Kwiatkowska, B., Żuber, Z. M., & Batko, B. (2024). Access to biologics and JAK inhibitors for the treatment of rheumatic diseases in the biosimilars era in Poland: nation-level study. Polish Archives of Internal Medicine. https://doi.org/10.20452/pamw.16655

Vancouver

Stajszczyk M, Kwiatkowska B, Żuber ZM, Batko B. Access to biologics and JAK inhibitors for the treatment of rheumatic diseases in the biosimilars era in Poland: nation-level study. Polish Archives of Internal Medicine. 2024. doi:10.20452/pamw.16655

BibTeX
@article{Stajszczyk2024,
  author = {Stajszczyk, Marcin and Kwiatkowska, Brygida and Żuber, Zbigniew M and Batko, Bogdan},
  title = {Access to biologics and JAK inhibitors for the treatment of rheumatic diseases in the biosimilars era in Poland: nation-level study},
  journal = {Polish Archives of Internal Medicine},
  year = {2024},
  doi = {10.20452/pamw.16655}
}
Kostenlos starten →